GNPX Genprex Inc.: ערך חשבונאי למניה

The book value per share for Genprex, Inc. (GNPX) is clearly displayed on GURU.Markets, with the current level sitting around 29.44. Genprex, Inc. leads in oncology gene therapy through the development of ONCOPRX AI-nanoparticles. The company relies on external contractors for manufacturing and testing, maintaining its position as a scientific hub. A lack of revenue and the pending FDA verdict deprive the business of the ability to exercise pricing power.

Geopolitical barriers and reagent supply disruptions are hindering the international research of Genprex, Inc. (GNPX), directly impacting the capitalization of its intangible assets. The current trend in book value per share reflects the equity portion per share, allowing investors to assess the business's intrinsic value without market noise and identify the risk of overpaying for the company's illiquid resources.